160 related articles for article (PubMed ID: 33116585)
1. MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma.
Li L; Li N; Liu N; Huo F; Zheng J
Onco Targets Ther; 2020; 13():10001-10012. PubMed ID: 33116585
[TBL] [Abstract][Full Text] [Related]
2. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract][Full Text] [Related]
3. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
Liu W; Wang N; Lu M; Du XJ; Xing BC
Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
[TBL] [Abstract][Full Text] [Related]
4. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Expression of miR-592 Is Associated with Prognosis and Progression of Renal Cell Carcinoma.
Lv X; Shen J; Guo Z; Kong L; Zhou G; Ning H
Onco Targets Ther; 2019; 12():11231-11239. PubMed ID: 31908489
[TBL] [Abstract][Full Text] [Related]
6. MCM5 promotes tumour proliferation and correlates with the progression and prognosis of renal cell carcinoma.
Gong B; Ma M; Yang X; Xie W; Luo Y; Sun T
Int Urol Nephrol; 2019 Sep; 51(9):1517-1526. PubMed ID: 31190295
[TBL] [Abstract][Full Text] [Related]
7. Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Mian OY; Wang SZ; Zhu SZ; Gnanapragasam MN; Graham L; Bear HD; Ginder GD
Mol Cancer Res; 2011 Aug; 9(8):1152-62. PubMed ID: 21693597
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Capns1 Predicts Poor Prognosis and Correlates with Tumor Progression in Renal Cell Carcinoma.
Zhuang Q; Fan M; Shen J; Chen Z; Xue D; Lu H; Xu R; He X; Hou J
Urol Int; 2021; 105(7-8):697-704. PubMed ID: 33887737
[TBL] [Abstract][Full Text] [Related]
9. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
10. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
11. Loss of
Liu Y; Wang H; Ni B; Zhang J; Li S; Huang Y; Cai Y; Mei H; Li Z
Cancer Manag Res; 2019; 11():1211-1220. PubMed ID: 30799948
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer.
Gong W; Ni M; Chen Z; Zheng Z
Oncol Lett; 2020 Sep; 20(3):2749-2756. PubMed ID: 32782591
[TBL] [Abstract][Full Text] [Related]
13. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
[TBL] [Abstract][Full Text] [Related]
14. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
[TBL] [Abstract][Full Text] [Related]
15. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
16. TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis
Shou Y; Liu Y; Xu J; Liu J; Xu T; Tong J; Liu L; Hou Y; Liu D; Yang H; Cheng G; Zhang X
Front Genet; 2022; 13():648134. PubMed ID: 35281807
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma.
Chen J; Wang XF; Qin YC; Gong YB; Wang L; Li NC
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11041-11051. PubMed ID: 33215419
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
